Delivery Order SPE2DB22D2005-SPE2DB25FJQT6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract with a ceiling value of $12.4k. The delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through open procurement...
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Prevnar 20 syringes (0.5mL) with a ceiling value of $9,802.68. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to be completed by August 1, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Prevnar 20 syringes (0.5ML) with a ceiling value of $6,535.08. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The contract is being performed at the company's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,078.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine syringes (0.5mL) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,673.16 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes on July 28, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. The delivery order represents a relatively small-value transaction within the federal pharmaceutical procurement landscape. This...
- The Defense Logistics Agency awarded a delivery order valued at $194,207.50 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5ml) under a firm fixed price contract. The award, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a direct procurement of this pneumococcal vaccine product to be performed at the vendor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes, with a contract ceiling value of $3,267.56 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on capability. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,495.60 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5 mL syringes, with a ceiling value of $14,344.50 under a firm fixed price contract type. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, leveraging its...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQT6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prevnar 20 syringes (0.5ML) with a ceiling value of $8,444.49. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 4, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies critical medical commodities including vaccines, medications, and medical supplies to support military and federal healthcare systems globally. The Prevnar 20 vaccine procurement supports the Defense Health Agency's pharmaceutical supply chain requirements and reflects the company's role as a primary vendor for federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 8/1/25 |